V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20023803 | 20010110 | 1.5 | 93.9 | Adjuvant (A) | 2016-06-14 | 2016-06-21 | FEC + DOCETAXEL | 2 | N | 20084113 | FEC + DOCETAXEL |
| 20023804 | 20010110 | 1.68 | 53.7 | Adjuvant (A) | 2013-10-31 | 2013-11-07 | FEC + DOCETAXEL | 02 | N | 20084113 | FEC + DOCETAXEL |
| 20023805 | 20010111 | 1.55 | 72.9 | Adjuvant (A) | 2017-11-04 | 2017-11-22 | FEC 100 + DOCETAXEL | N | null | 20084135 | FEC + DOCETAXEL |
| 20023806 | 20010112 | 1.68 | 54 | null | 2016-01-11 | 2016-02-03 | FEC + DOCETAXEL | N | N | 20084137 | FEC + DOCETAXEL |
| 20023807 | 20010112 | 1.63 | 58.8 | Adjuvant (A) | 2013-07-01 | 2013-07-01 | FEC + DOCETAXEL | 02 | N | 20084137 | FEC + DOCETAXEL |
| 20023808 | 20010112 | 1.67 | 73 | Adjuvant (A) | 2017-07-12 | 2017-08-11 | FEC + DOCETAXEL | N | N | 20084137 | FEC + DOCETAXEL |
| 20023809 | 20010112 | 1.57 | 85 | Adjuvant (A) | null | 2015-10-10 | FEC 100 + DOCETAXEL | N | N | 20084137 | FEC + DOCETAXEL |
| 20023810 | 20010112 | 1.57 | 66 | Neo-adjuvant (N) | 2015-08-28 | 2015-08-30 | FEC + DOCETAXEL | 02 | N | 20084137 | FEC + DOCETAXEL |
| 20023811 | 20010113 | 1.52 | 57.2 | Adjuvant (A) | null | 2014-06-05 | FEC 100 + DOCETAXEL | N | N | 20084154 | FEC + DOCETAXEL |
| 20023812 | 20010113 | 1.75 | 109.5 | Adjuvant (A) | 2013-12-27 | 2014-01-10 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20084154 | FEC + DOCETAXEL |
| 20023813 | 20010114 | 1.68 | 67 | Curative (C) | 2016-11-03 | 2016-11-04 | FEC + DOCETAXEL | 2 | N | 20084162 | FEC + DOCETAXEL |
| 20023814 | 20010115 | 0.59 | 54 | Adjuvant (A) | 2013-07-04 | 2013-07-12 | FEC + DOCETAXEL | 99 | N | 20084166 | FEC + DOCETAXEL |
| 20023815 | 20010115 | 1.62 | 72.85 | Adjuvant (A) | 2016-11-27 | 2016-12-27 | FEC + DOCETAXEL | N | N | 20084166 | FEC + DOCETAXEL |
| 20023816 | 20010115 | 1.63 | 77.4 | Neo-adjuvant (N) | 2017-05-24 | 2017-05-24 | FEC + DOCETAXEL | 02 | N | 20084166 | FEC + DOCETAXEL |
| 20023817 | 20010116 | 1.67 | 79.45 | Adjuvant (A) | 2015-02-17 | 2015-02-17 | FEC 100 + DOCETAXEL | 2 | N | 20084172 | FEC + DOCETAXEL |
| 20023818 | 20010117 | 1.62 | 136.6 | Adjuvant (A) | 2016-06-10 | 2016-06-26 | FEC 100 + DOCETAXEL | N | N | 20084173 | FEC + DOCETAXEL |
| 20023819 | 20010117 | 1.73 | 48.2 | Adjuvant (A) | 2014-02-21 | 2014-03-10 | FEC + DOCETAXEL | 02 | N | 20084173 | FEC + DOCETAXEL |
| 20023820 | 20010118 | 1.72 | 110 | Not known (9) | 2016-05-30 | 2016-06-06 | FEC + DOCETAXEL | 2 | Y | 20084177 | FEC + DOCETAXEL |
| 20023821 | 20070825 | 1.76 | 84.4 | Adjuvant (A) | null | 2016-07-30 | FEC + DOCETAXEL | N | null | 20084178 | FEC + DOCETAXEL |
| 20023822 | 20010119 | 1.57 | 63.4 | Neo-adjuvant (N) | 2015-08-21 | 2015-08-24 | FEC 100 + DOCETAXEL | N | N | 20084181 | FEC + DOCETAXEL |
| 20023823 | 20010119 | 1.63 | 63 | Adjuvant (A) | 2015-02-19 | 2015-02-21 | FEC + DOCETAXEL | 02 | N | 20084181 | FEC + DOCETAXEL |
| 20023824 | 20010120 | 1.5 | 110.4 | Neo-adjuvant (N) | null | 2016-03-22 | FEC 100 + DOCETAXEL | N | N | 20084188 | FEC + DOCETAXEL |
| 20023825 | 20010120 | 1.68 | 64.5 | Neo-adjuvant (N) | 2015-12-23 | 2015-12-23 | FEC + DOCETAXEL | N | N | 20084188 | FEC + DOCETAXEL |
| 20023826 | 20010121 | null | 71 | Neo-adjuvant (N) | 2016-07-18 | 2016-08-09 | FEC + DOCETAXEL | N | null | 20084200 | FEC + DOCETAXEL |
| 20023827 | 20070828 | null | 66 | Adjuvant (A) | 2015-04-02 | 2015-04-07 | FEC + DOCETAXEL | 99 | N | 20084201 | FEC + DOCETAXEL |
| 20023828 | 20010122 | 1.66 | 57.9 | null | 2014-04-30 | 2014-05-26 | FEC + DOCETAXEL | N | N | 20084206 | FEC + DOCETAXEL |
| 20023829 | 20010122 | 1.61 | 55.8 | Adjuvant (A) | 2015-05-12 | 2015-05-12 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20084206 | FEC + DOCETAXEL |
| 20023830 | 20108384 | 1.63 | 75 | Neo-adjuvant (N) | 2016-09-02 | 2016-09-14 | FEC 100 + DOCETAXEL | 02 | N | 20084209 | FEC + DOCETAXEL |
| 20023831 | 20010123 | 1.71 | 57.9 | Adjuvant (A) | 2012-12-21 | 2017-09-28 | FEC + DOCETAXEL | 2 | N | 20084211 | FEC + DOCETAXEL |
| 20023832 | 20010123 | 1.74 | 67.3 | Adjuvant (A) | null | 2017-04-02 | FEC + DOCETAXEL | N | N | 20084211 | FEC + DOCETAXEL |
| 20023833 | 20010123 | 1.7 | 95.2 | Adjuvant (A) | null | 2015-07-23 | FEC + DOCETAXEL | N | N | 20084211 | FEC + DOCETAXEL |
| 20023834 | 20010123 | null | 107.9 | Neo-adjuvant (N) | 2013-02-02 | 2013-02-06 | FEC + DOCETAXEL | 02 | N | 20084211 | FEC + DOCETAXEL |
| 20023835 | 20010123 | 1.66 | null | Adjuvant (A) | 2017-08-24 | 2017-09-07 | FEC + DOCETAXEL | 2 | N | 20084211 | FEC + DOCETAXEL |
| 20023836 | 20010124 | 1.66 | 53.9 | Adjuvant (A) | null | 2017-11-05 | FEC + DOCETAXEL | N | N | 20084222 | FEC + DOCETAXEL |
| 20023837 | 20010124 | 1.56 | 70.2 | Adjuvant (A) | null | 2015-03-05 | FEC + DOCETAXEL | N | N | 20084222 | FEC + DOCETAXEL |
| 20023838 | 20010124 | 1.76 | 55.4 | Adjuvant (A) | 2016-12-17 | 2016-12-18 | FEC + DOCETAXEL | 2 | N | 20084222 | FEC + DOCETAXEL |
| 20023839 | 20010124 | 1.6 | 77.8 | Adjuvant (A) | 2015-04-21 | 2015-04-21 | FEC + DOCETAXEL | 02 | N | 20084222 | FEC + DOCETAXEL |
| 20023840 | 20010124 | 1.62 | 109 | Adjuvant (A) | 2015-07-10 | 2015-08-04 | FEC + DOCETAXEL | 2 | null | 20084222 | FEC + DOCETAXEL |
| 20023841 | 20010125 | 1.72 | 85.5 | Adjuvant (A) | 2017-02-26 | 2017-02-27 | FEC 100 + DOCETAXEL | 2 | N | 20084254 | FEC + DOCETAXEL |
| 20023842 | 20010125 | 1.64 | 84 | null | 2015-05-14 | 2015-05-28 | FEC 100 + DOCETAXEL | N | N | 20084254 | FEC + DOCETAXEL |
| 20023843 | 20010125 | 1.54 | 69 | Adjuvant (A) | 2013-12-13 | 2014-01-01 | FEC + DOCETAXEL | 02 | N | 20084254 | FEC + DOCETAXEL |
| 20023844 | 20010125 | 1.71 | 72 | Adjuvant (A) | 2017-01-05 | 2017-01-15 | FEC + DOCETAXEL | 2 | N | 20084254 | FEC + DOCETAXEL |
| 20023845 | 20010125 | 1.68 | null | Adjuvant (A) | 2016-10-29 | 2016-11-05 | FEC + DOCETAXEL | N | Y | 20084254 | FEC + DOCETAXEL |
| 20023846 | 20010126 | 1.66 | 49.15 | Neo-adjuvant (N) | 2016-10-29 | 2016-11-06 | FEC 100 + DOCETAXEL | 02 | null | 20084294 | FEC + DOCETAXEL |
| 20023847 | 20010126 | 1.71 | 62.6 | Adjuvant (A) | 2013-06-05 | 2013-06-09 | FEC + DOCETAXEL | 02 | N | 20084294 | FEC + DOCETAXEL |
| 20023848 | 20108388 | 1.47 | 76.6 | Adjuvant (A) | 2015-01-01 | 2015-01-16 | FEC 100 + DOCETAXEL | 02 | N | 20084307 | FEC + DOCETAXEL |
| 20023849 | 20010127 | 1.66 | 88 | Adjuvant (A) | 2017-03-08 | 2017-03-15 | FEC + DOCETAXEL | 02 | N | 20084312 | FEC + DOCETAXEL |
| 20023850 | 20070834 | 1.58 | 89 | Adjuvant (A) | 2017-03-01 | 2017-03-11 | FEC + DOCETAXEL | 2 | N | 20084314 | FEC + DOCETAXEL |
| 20023851 | 20010128 | 1.76 | 63 | Neo-adjuvant (N) | null | 2014-08-22 | FEC + DOCETAXEL | N | N | 20084321 | FEC + DOCETAXEL |
| 20023852 | 20010128 | null | 53.6 | Adjuvant (A) | 2013-07-09 | 2013-07-23 | FEC + DOCETAXEL | null | N | 20084321 | FEC + DOCETAXEL |